Status:
COMPLETED
Targeting of UnControlled Hypertension in Emergency Department
Lead Sponsor:
University of Illinois at Chicago
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Hypertension
Cardiovascular Diseases
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The proposed project underscores the following: 1) The prevalence of uncontrolled/undiagnosed hypertension (HTN) in underrepresented groups presenting to the ED is alarmingly high, and 2) ED engagemen...
Detailed Description
The study is a single-site randomized controlled trial (RCT) focused on a high-risk ED population with evidence of moderately elevated BP (≥140/90 mmHg) at discharge. ED patients will be recruited and...
Eligibility Criteria
Inclusion
- BP\>=140/90 and \<=180/110 mm Hg at time of discharge from ED
- Verbal fluency in English or Spanish
- Age 18-75 years
Exclusion
- Unable to verbalize comprehension of study, impaired decision-making or documented dementia
- Plans to move from Chicago area within the next year
- Pregnant or trying to get pregnant
- COVID-19 positive within the past 14 days
Key Trial Info
Start Date :
February 19 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2023
Estimated Enrollment :
574 Patients enrolled
Trial Details
Trial ID
NCT03749499
Start Date
February 19 2019
End Date
March 31 2023
Last Update
June 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Illinois at Chicago
Chicago, Illinois, United States, 60612